{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:32:44Z","timestamp":1648823564082},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.expneurol.2012.05.024","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T05:23:29Z","timestamp":1339219409000},"page":"43-45","source":"Crossref","is-referenced-by-count":2,"title":["Neural development, a risky period"],"prefix":"10.1016","volume":"237","author":[{"given":"John R.","family":"Sladek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.05.024_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.reprotox.2007.01.007","article-title":"The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder","volume":"23","author":"Barlow","year":"2007","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0010","first-page":"83","article-title":"Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat","volume":"14","author":"Bayer","year":"1993","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0015","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(83)90802-4","article-title":"Aetiology of Parkinson's disease","volume":"2","author":"Calne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3727\/000000006783981990","article-title":"Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis","volume":"15","author":"Carvey","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0030","first-page":"548","article-title":"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey","volume":"20","author":"Chiueh","year":"1984","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(01)00171-3","article-title":"Translating developmental time across mammalian species","volume":"105","author":"Clancy","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuro.2007.01.014","article-title":"Extrapolating brain development from experimental species to humans","volume":"28","author":"Clancy","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35046114","article-title":"Coenzyme Q is an obligatory cofactor for uncoupling protein function","volume":"408","author":"Echtay","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0050","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/138920107780906540","article-title":"Adult neurogenesis: can analysis of cell cycle proteins move us \"Beyond BrdU\"?","volume":"8","author":"Eisch","year":"2007","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0055","first-page":"735","article-title":"Prehistory of Parkinson's disease","volume":"19","author":"Garcia Ruiz","year":"2004","journal-title":"Neurologia"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuro.2006.03.015","article-title":"Amphetamine exposure is elevated in Parkinson's disease","volume":"27","author":"Garwood","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0065","author":"Goetz"},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2012.05.024_bb0070","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S1353-8020(03)00023-3","article-title":"The rotenone model of Parkinson's disease: genes, environment and mitochondria","volume":"9","author":"Greenamyre","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson's disease","volume":"31","author":"Greenamyre","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0080","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/en.2003-0163","article-title":"Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease","volume":"144","author":"Horvath","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1254\/jphs.92.178","article-title":"Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption","volume":"92","author":"Kita","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.expneurol.2007.01.009","article-title":"Apoptotic natural cell death in developing primate dopamine midbrain neurons occurs during a restricted period in the second trimester of gestation","volume":"204","author":"Morrow","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2011.05.046","article-title":"Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease","volume":"189","author":"Morrow","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.expneurol.2012.02.005","article-title":"Susceptibility to a parkinsonian toxin varies during primate development","volume":"235","author":"Morrow","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/appi.neuropsych.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0120","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0140-6736(86)91839-8","article-title":"Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine","volume":"1","author":"Redmond","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.2903552","article-title":"Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys","volume":"242","author":"Redmond","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0110","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.1073\/pnas.0704091104","article-title":"Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells","volume":"104","author":"Redmond","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1749-6632.1992.tb24586.x","article-title":"Neurotoxic amphetamine analogues: effects in monkeys and implications for humans","volume":"648","author":"Ricaurte","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0361-9230(86)90092-4","article-title":"Survival and growth of fetal catecholamine neurons transplanted into primate brain","volume":"17","author":"Sladek","year":"1986","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/exnr.1993.1103","article-title":"Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates","volume":"122","author":"Sladek","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.024_bb0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0161-813X(02)00092-X","article-title":"Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype","volume":"23","author":"Thiruchelvam","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0145","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1093\/brain\/awr256","article-title":"The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain","volume":"134","author":"van den Berge","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2012.05.024_bb0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cercor\/8.4.321","article-title":"Widespread origin of the primate mesofrontal dopamine system","volume":"8","author":"Williams","year":"1998","journal-title":"Cereb. Cortex"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861200235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861200235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T22:52:42Z","timestamp":1542927162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861200235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S001448861200235X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.05.024","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}